SmartCells is developing a modified version of insulin for diabetics.
100 Cummings Center
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Conjugate based systems for controlled drug delivery||May 30, 2014||Feb 23, 2016||Patent|
|Recombinant lectins, binding-site modified lectins and uses thereof||Jul 22, 2011||Jun 30, 2015||Patent|